Guidance for ARIKAYCE remains unchanged at $405 million to $425 million for full-year 2025. The company reiterated its focus on achieving a smooth launch for brensocatib in the U.S. and expanding its ...

Q1 2025 Management View Harvey Schwartz, CEO, highlighted record fee-related earnings of $311 million, a 17% year-over-year ...

Private equity group Carlyle delivered stronger than expected first-quarter results that signal the US buyout pioneer is ...

The Fed remains in a “holding pattern” amid uncertainty surrounding the impact of tariffs on the economy, with “the odds skewed towards” keeping interest rates at the current level at its June policy ...

Trump’s pause of the Foreign Corrupt Practices Act has left companies confused and cast doubt on US leadership of ...

Korea Investment & Securities Co. (KIS), the brokerage unit of Korea Investment Holdings Co., said on Wednesday it hosted its ...

Shares of healthcare services company Sotera Health (NASDAQ:) jumped 5.9% in the pre-market session after Goldman Sachs ...

Melissa Goldman returned to Wall Street after stints at Goldman Sachs, JPMorgan, and Google. She discusses the evolving role ...

Wilshire has appointed Jason Schwarz to Chief Executive Officer. He succeeds current CEO, Andy Stewart, who will assume the ...

Attackers follow three predictable paths to commit crimes: social engineering, compromised email and vulnerable network ...

Despite mounting financial pressure, China says it won't negotiate until the Trump administration shows 'sincerity' by ...

Goldman Sachs removes the word ‘Black’ from diversity programs as Trump continues to pressure companies to end DEI - Program ...